Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NATR
NATR logo

NATR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nature's Sunshine Products Inc (NATR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.050
1 Day change
-3.22%
52 Week Range
28.140
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NATR is not a clear buy right now for a beginner long-term investor with $50,000-$100,000, but it also does not look like an outright sell. The stock has constructive technicals and a favorable analyst target upgrade, yet the lack of recent news, insider selling, and no strong proprietary buy signal keep the setup from being a strong immediate entry. Since the user is impatient and does not want to wait for an ideal entry, my direct view is hold rather than buy at this moment.

Technical Analysis

The stock closed at 21.47, below the day’s implied resistance levels but near pivot support at 21.088. MACD histogram is positive at 0.309, though contracting, which suggests momentum is still mildly bullish but weakening. RSI_6 at 60.746 is neutral-to-bullish, not overbought. Moving averages are converging, indicating a potentially emerging trend but not a strong breakout yet. Short-term pattern data suggests mixed near-term performance, with downside probability slightly outweighing immediate upside. Overall, the chart is constructive but not strong enough to justify a decisive buy today.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment looks bullish based on the low put-call open interest ratio of 0.24, implying call positioning dominates puts. However, there was no option volume today, so the sentiment is based more on positioning than active trading flow. Implied volatility is relatively low with IV rank at 3.96 and IV percentile at 3.17, suggesting the market is not pricing in much event risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • ["Canaccord raised its price target to $37 from $33 and reiterated a Buy rating.", "Management reported better-than-expected Q1 results.", "Expansion plans into Germany and two new high-value Asian markets could support future growth.", "Synergy brand rollout into the U.S. through affiliates may broaden the addressable market.", "Options positioning is bullish with a low put-call open interest ratio."]

Neutral/Negative Catalysts

  • ["No recent news in the past week, so there is no fresh catalyst.", "Insiders have been selling, and the selling amount increased 161.97% over the last month.", "Hedge funds are neutral with no significant trading trend over the last quarter.", "No recent congress trading data is available.", "No strong Intellectia proprietary buy signal is present today."]

Financial Performance

The latest quarter referenced is Q1, and management said results were better than expected. That implies improving operating performance and a positive growth trend, but the provided data does not include revenue, earnings, or margin figures, so the strength of the quarter cannot be fully quantified. The growth narrative is still favorable because the company is expanding internationally and management appears confident in execution.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is positive overall. Canaccord raised its price target to $37 from $33 and maintained a Buy rating after stronger-than-expected Q1 results. This is a bullish analyst update and suggests Wall Street sees upside, but the broader pros-and-cons view is mixed because insider selling and the lack of strong near-term trading signals offset some of that optimism.

Wall Street analysts forecast NATR stock price to rise
2 Analyst Rating
Wall Street analysts forecast NATR stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 21.750
sliders
Low
22
Averages
22.5
High
23
Current: 21.750
sliders
Low
22
Averages
22.5
High
23
Canaccord
Buy
maintain
$33 -> $37
AI Analysis
2026-05-08
Reason
Canaccord
Price Target
$33 -> $37
AI Analysis
2026-05-08
maintain
Buy
Reason
Canaccord raised the firm's price target on Nature's Sunshine to $37 from $33 and keeps a Buy rating on the shares. The firm said they reported better than expected Q1 results. Management highlighted plans to enter Germany and expand into two new high-value Asian markets using the Synergy Asia sales system. Management also noted they are rolling out the Synergy brand to the U.S. market through affiliates that know the brand well in Asia.
DA Davidson
Buy
maintain
$23 -> $33
2026-03-12
Reason
DA Davidson
Price Target
$23 -> $33
2026-03-12
maintain
Buy
Reason
DA Davidson raised the firm's price target on Nature's Sunshine to $33 from $23 and keeps a Buy rating on the shares. The company's beat and raise trend continues with Q4 results comfortably above consensus forecasts, and the firm sees further upward revisions as results underscore the extent to which the company's portfolio is under-penetrated across key markets, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NATR
Unlock Now

People Also Watch